Alpenglow Biosciences Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Alpenglow Biosciences has 24 Employees.(i)
  • Alpenglow Biosciences grew their employee count by 0% last year.

Alpenglow Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Strategy OperationsReveal Email/Phone
3
SVP, Commercial DevelopmentReveal Email/Phone
4
Director EngineeringReveal Email/Phone
5
Senior Manager, Commercial DevelopmentReveal Email/Phone
6
Software EngineerReveal Email/Phone
7
Lead ScientistReveal Email/Phone
8
Cloud EngineerReveal Email/Phone
9
Algorithm EngineerReveal Email/Phone
10
Financial AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A240%N/AN/A
#2
$7.5M1317%N/AN/A
#3
$3.5M6520%N/AN/A
#4
N/A57621%N/AN/A
#5
N/A2624%$4MN/A
#6
N/A57621%N/AN/A
#7
N/A1467%N/AN/A
#8
$7.5M675%N/AN/A
Add Company

What Is Alpenglow Biosciences?

Founded in 2018, Seattle-based Alpenglow Biosciences is a privately held, early-stage life sciences company focused on accelerating drug development and improving clinical diagnostics with AI-enabled, 3D imaging technology. Our platform solution provides new spatial biology insights with greater accuracy by digitizing entire tissues while keeping samples intact for additional analysis. Alpenglow partners with pharmaceutical companies to develop better therapeutics and greater understanding of biodistribution, mechanism of action, and rank ordering of potential candidates using our patented technology. Five of the top 10 pharma companies work with Alpenglow to accelerate development timelines, gain new insights, and improve therapeutic success.We are hiring talented individuals for roles in business development, wet lab, hardware, and software.

keywords:N/A

N/A

Total Funding

24

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M24-4%N/A
#2
$3.2M24-4%$228M
#3
$2M24-33%$2.5M
#4
$2.4M24N/AN/A
#5
$3.5M240%N/A